Scientific Library

mRNA-Based Therapeutics: Pioneering the Future of Medicine

Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including cancer, infectious

Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms

In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been more urgent—or

Advancing Live-Cell Actin Imaging with Spirochrome New Products

Actin cytoskeleton imaging is a cornerstone of cellular biology, playing a pivotal role in understanding cell motility, morphology, and

Looking for high-quality mRNA, nucleotides, and custom oligonucleotides?Tebubio delivers the complete TriLink catalogue, giving researchers easy access to industry-leading reagents.

Explore how to optimize Lipid Nanoparticules (LNP) for mRNA delivery for druf development. This study highlights key formulation parameters: buffer composition, lipid selection; crucial for enhancing transfection

Discover how ELISA-based methods enable precise PARylation assessment in intact cells. Learn about the role of PARP and PARG inhibitors in drug discovery and cancer research.

Explore commercial kits for

Discover the LIVE-Step™ Cell Assay System: a fast, sensitive, and cost-effective solution for measuring cell viability in drug screening, cancer research, and toxicity studies.

Learn how this ATP-based

In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and

In this blog, we delve into the potential of Gamma Delta (γδ) T cells in the development of new cancer treatment, and how thanks to the tools developed by our partner BPS Bioscience we can support you

Boost the reliability of your Immuno-Oncology research with Tebubio’s expert selection of iXCells immune cells.

From fresh PBMCs to CD4+, CD8+, NK cells and beyond—this resource highlights the best tools

In this blog, discover three assay kits developed by our partner Dojindo to accurately quantify and detect SA-β-Gal activity, and to explore a broad range of cellular processes linked to senescence.

Explore 500+ anti-cancer compounds for oncology drug discovery. This ready-to-screen library supports cell-based assays and mechanism-specific screens. Now available through Tebubio.